Company builds expansion strategy around institutional payments and treasury services as global stablecoin market grows 48.9% and business payment activity accelerates

HONG KONG, Sept. 18, 2026 (GLOBE NEWSWIRE) — SOLOWIN HOLDINGS (Nasdaq: AXG) reported $28.05 million in revenue for the fiscal year ended March 31, 2026, approximately 895% above $2.82 million a year earlier. Stablecoin and fiat trading volume increased 395% to $1.04 billion, adding approximately $830 million in annual activity as the company develops its institutional digital-finance business.

AXG’s operating progress extended across its platforms. Client assets under administration increased 347% to $848.8 million, AX ONE processed $226 million in payment volume, and FERION completed 10 tokenization projects representing $52 million in value. AI infrastructure contributed approximately $22.2 million, or 79% of group revenue, while Digital Asset Tokens contributed approximately $5.6 million. The company recorded a $13.29 million net loss.

The results place AXG’s expansion against a substantial increase in global stablecoin adoption. Stablecoin market capitalization grew 48.9% during calendar 2025, adding $102.1 billion to reach $311 billion. AXG’s revenue increased nearly tenfold during its fiscal year; company revenue, trading activity and industry market capitalization are distinct measures with different reporting periods.

A concentrated market with emerging institutional alternatives.

Tether’s USDT and Circle’s USDC remain the dominant stablecoins. At June 2026, their respective market capitalizations of $184.4 billion and $73.5 billion represented approximately 84.5% of the $305.1 billion global stablecoin market. Separately, Tiger Research estimated in February 2026 that approximately 99% of stablecoin market capitalization was U.S. dollar-pegged, underscoring both demand for digital dollars and policy concerns surrounding domestic-currency sovereignty.

Regional payment activity is beginning to diversify. CoinDesk Research reports that USDT’s share of identified Asia-Pacific stablecoin payment volume declined from 98% at the beginning of 2025 to 91% in July 2026. The shift suggests growing participation by alternative stablecoins as institutions evaluate licensing, reserve transparency, custody and integration capabilities alongside liquidity.

Business payments create a measurable expansion opportunity

McKinsey and Artemis estimate that stablecoin payments reached $390 billion on an annualized basis using December 2025 activity, more than double the previous year’s level. Business-to-business payments accounted for approximately $226 billion, increasing 733% year over year.

Asia-originated payments represented approximately $245 billion, followed by $95 billion from North America and $50 billion from Europe. These flows provide a commercial foundation for institutional supplier payments, cross-border settlement, payroll and treasury management.

Inflation and transaction costs reinforce the demand for more efficient financial services. Annual inflation reached 33.5% in Argentina and 31.51% in Türkiye in August 2026, while the World Bank’s third-quarter 2025 benchmark placed the average cost of sending a $200 remittance at 6.36%. Such conditions can encourage demand for dollar access and lower-cost transfers, although a dollar peg does not eliminate U.S. inflation exposure.

From regulatory capability to recurring commercial activity

Following AX Coin Bahrain’s receipt of its full stablecoin issuer license in June 2026, AXG’s stated priorities include commercializing AXUSD and AXBHD, integrating banking and payment partners, and developing GCC–Asia and GCC–Africa payment corridors. Commercial milestones include live integrations, transacting institutional customers and payment-volume growth. Product launches remain subject to applicable approvals and operational readiness.

Ling Ngai Lok, Chairman and CEO of Solowin,

“First, the mechanics, because most people missed them. Monday’s vote wasn’t on the CLARITY Act itself. It was a cloture vote on the motion to proceed — a procedural gate that needs 60 senators just to open floor debate. It got 49, against 50. Every Republican but four voted yes; the Democrats who had negotiated the text for months voted no, over an ethics clause on politicians’ own crypto holdings. Nobody voted against the substance: a clear split of digital asset oversight between the SEC and the CFTC, with the CFTC taking digital commodities and the SEC keeping securities. That framework passed the House 294 to 134 and cleared Senate Banking 15 to 9. It’s still on the Senate calendar. The battle is not over.

I want to thank the people who did the work — Senator Lummis and the Banking and Agriculture committee staff, the House sponsors who moved it last year, and the teams at both commissions who have been drafting rules in parallel. More than a hundred amendments were absorbed to get this far. That effort isn’t wasted; it’s the base for the next attempt.

And here’s why I’m optimistic. Both commissions are moving regardless. The CFTC chairman said this week he’ll act under existing statutory authority. The SEC’s crypto rulemaking is open for comment until October 20. Stablecoins already have their federal law in GENIUS. So the U.S. market structure is being built right now, agency by agency, with Congress catching up.

Best of all, it’s happening in public. Imagine this had passed quietly, buried in a spending bill — most of the market would have learned about it a year late. Instead it’s the biggest story in finance this week. Every institution, treasury desk and family office is being forced to form a view on digital assets now. More attention brings more participants, more participants bring deeper liquidity, and liquidity is what turns crypto from a trade into a market.

AXG chose the license-first path early — central-bank oversight in Bahrain, the SFC framework in Hong Kong. When the U.S. rules land, we won’t be scrambling. We’ll be operating. Washington’s delay isn’t a threat to us. It’s runway.”

Media contact
Charlotte QI
ir@solowin.io 

Order covers unmanned aerial systems and associated support. A separate memorandum frames expanded cooperation, subject to definitive agreements and government approvals

  • Limited procurement order received from the Ministry of Defence of the Islamic Republic of Pakistan for unmanned aerial systems and associated support.
  • Order represents an expansion of Powerus’s international defense business.
  • Separate memorandum of understanding frames expanded cooperation in unmanned and autonomous systems, subject to definitive agreements and government approvals.
  • Powerus delegation received by the Chief of Army Staff at General Headquarters, Rawalpindi, per a statement issued by Inter-Services Public Relations.
  • Powerus has entered into a definitive merger agreement with Aureus Greenway Holdings Inc. (Nasdaq: PUSA). The proposed merger remains subject to customary closing conditions.

ORLANDO, Fla. and WEST PALM BEACH, Fla., Sept. 18, 2026 (GLOBE NEWSWIRE) — Aureus Greenway Holdings Inc. (“AGH”) (Nasdaq: PUSA) and Autonomous Power Corporation, doing business as Powerus (“Powerus”), today jointly announced that it has received a limited procurement order from the Ministry of Defence of the Islamic Republic of Pakistan for unmanned aerial systems and associated support.

The order represents an expansion of Powerus’s international defense business. No other terms of the order have been disclosed.

Powerus has also signed a strategic memorandum of understanding with senior defense officials of the Islamic Republic of Pakistan. The memorandum establishes a framework for potential expanded cooperation in unmanned and autonomous defense technologies and provides a basis for the parties to explore additional areas of cooperation and potential future deployment of Powerus systems. The memorandum is not a definitive agreement, creates no purchase obligation, and does not obligate either party to proceed. Any program or procurement contemplated under the framework would be subject to definitive agreements and to all applicable United States laws and regulations and government approvals.

On September 16, 2026, a Powerus delegation led by Co-Founder Brett Velicovich was received by Field Marshal Syed Asim Munir, Chief of Army Staff and Chief of Defence Forces, at General Headquarters in Rawalpindi. In a statement issued by Inter-Services Public Relations, the media wing of the Pakistan Armed Forces, the meeting was described as covering matters of mutual interest, evolving trends in defence technology, and avenues for cooperation in defence procurement, production and capacity building. The statement said both sides expressed interest in further developing engagement in areas of mutual interest.

“This is an important milestone for Powerus as we expand our international defense footprint,” said Brett Velicovich, Co-Founder of Powerus. “We are proud to support Pakistan’s Ministry of Defence, and the memorandum gives both sides a strategic framework to build upon.”

“We are pleased to jointly announce this milestone with Powerus,” said Matthew Saker, Interim Chief Executive Officer of AGH. “The Ministry of Defence order and the strategic memorandum of understanding reflect the kind of international defense traction that we believe supports the strategic rationale for the pending combination.”

About POWERUS

Powerus (Autonomous Power Corporation) builds and scales unified autonomous systems designed to move, protect, and sustain critical assets in high-risk environments, with capabilities spanning heavy-lift platforms, autonomous air systems, autonomous maritime systems, mission systems, training and support, and U.S.-based manufacturing. Powerus previously announced a proposed merger with AGH (Nasdaq: PUSA); the merger has not closed and remains subject to the satisfaction of customary closing conditions and applicable regulatory approvals. Learn more at power.us.

ABOUT AUREUS GREENWAY HOLDINGS, INC.

Aureus Greenway Holdings Inc. (Nasdaq: PUSA) currently owns and operates golf course properties in Florida, including Kissimmee Bay Country Club and Remington Golf Club in the greater Orlando region. AGH has filed a registration statement on Form S-4 with the SEC, which includes an information statement and prospectus, in connection with its proposed business combination with Powerus. The registration statement was declared effective on August 12, 2026. Learn more at aureusgreenway.com.

Each of AGH and Powerus has provided the information herein relating to its own business, operations, financial condition, technology, products, certifications, contracts, and prospects. Neither party has independently verified the other party’s information, and each party disclaims any representation or warranty, express or implied, as to the accuracy, completeness, or reliability of the other party’s information.

PROPOSED MERGER

Powerus has previously announced a proposed merger with Aureus Greenway Holdings Inc. (Nasdaq: PUSA). Under the terms of the previously announced agreement, Powerus will merge with and into a newly formed subsidiary of AGH, with Powerus continuing as the surviving entity and AGH adopting the name “Powerus Corporation.” AGH has changed its Nasdaq ticker to PUSA in anticipation of its pending combination with Powerus, expected to close in Q4 2026, subject to customary closing conditions, including the effectiveness of a registration statement on Form S-4 (declared effective August 12, 2026) and receipt of required regulatory approvals. There can be no assurance that the proposed transactions will be consummated or as to the timing of any such consummation.

FORWARD-LOOKING STATEMENTS

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. As to the Pakistan Ministry of Defence order and the memorandum of understanding described in this release, these statements include, without limitation, statements regarding the scope and performance of the order; the memorandum of understanding and the prospect of expanded cooperation; anticipated demand for unmanned and autonomous defense systems; and the ability to obtain and maintain required export and regulatory authorizations. Forward-looking statements may be identified by terminology such as “may,” “will,” “should,” “targets,” “plans,” “intends,” “goal,” “anticipates,” “expects,” “believes,” “potential,” or “continue” or negatives of such terms or other comparable terminology. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially.

As to the proposed business combination between Powerus and AGH, these statements include, without limitation, statements regarding the proposed merger between Powerus and AGH; the anticipated benefits of the merger; the registration statement on Form S-4, the declaration of effectiveness by the SEC, and the SEC’s review process; the expected timing of the completion of the merger; the anticipated listing and trading of the combined company’s securities; future financial and operating results; the plans, objectives, expectations and intentions of either company or of the combined company following the merger; anticipated future results of either company or of the combined company following the merger; and the anticipated benefits and strategic and financial rationale of the merger and other statements that are not historical facts and its expected timing.

All forward-looking statements are subject to risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from any results expressed or implied by such forward-looking statements. As to the Pakistan Ministry of Defence order and the memorandum of understanding described in this release, such factors include, among others: (1) that the memorandum of understanding is not a definitive agreement, creates no purchase obligation, and does not obligate either party to proceed, and that any program or procurement contemplated under the framework would be subject to definitive agreements and to all applicable United States laws and regulations and government approvals; (2) that the order does not guarantee future orders, a continuing relationship, or additional procurement; (3) that required export licenses, authorizations, permits, or other governmental consents may be delayed, denied, suspended, revoked, or made subject to conditions; (4) political, security, regulatory, and economic conditions in Pakistan; (5) risks relating to production, delivery, and reliance on third-party suppliers; and (6) other Powerus-specific operational uncertainties.

As to the announced merger agreement, such factors include, among others: (1) the risk of delays in consummating the potential transaction, including as a result of required shareholder and regulatory approvals, including Nasdaq listing requirements which may not be obtained on the expected timeline, or at all; (2) the risk of any event, change or other circumstance that could give rise to the termination of the merger agreement; (3) the possibility that any of the anticipated benefits and projected synergies of the potential transactions will not be realized or will not be realized within the expected time period; (4) the limited operational history of Powerus as a combined organization and integration risks of acquired businesses; (5) diversion of management’s attention or disruption to the parties’ businesses as a result of the announcement and pendency of the transaction, including potential distraction of management from current plans and operations of AGH or Powerus and the ability of AGH or Powerus to retain and hire key personnel; (6) reputational risk and the reaction of each company’s customers, suppliers, employees or other business partners to the transaction; (7) the possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events; (8) the outcome of any legal or regulatory proceedings that may be instituted against AGH or Powerus related to the merger agreement or the transaction; (9) the risks associated with third party contracts containing consent and/or other provisions that may be triggered by the proposed transaction; (10) legislative, regulatory, political, market, economic and other conditions, developments and uncertainties affecting AGH’s or Powerus’s businesses; (11) the evolving legal, regulatory, tax, and international trade regimes; (12) the nature, cost and outcome of potential litigation and other legal proceedings, including any such proceedings related to the transactions; (13) restrictions during the pendency of the proposed transaction that may impact AGH’s or Powerus’s ability to pursue certain business opportunities or strategic transactions; and (14) unpredictability and severity of catastrophic events, including, but not limited to, extreme weather, natural disasters, acts of terrorism or outbreak of war or hostilities, as well as AGH’s and Powerus’s response to any of the aforementioned factors.

In connection with the proposed merger, AGH has filed relevant materials with the SEC, including a registration statement on Form S-4, which includes an information statement and prospectus, and may file additional materials in the future. Investors and security holders are urged to read those materials because they contain important information. Forward-looking statements speak only as of the date of this release, and except as required by law, neither company undertakes any obligation to update them. This release does not constitute an offer to sell or the solicitation of an offer to buy any securities.

NO OFFER OR SOLICITATION

This document is for informational purposes only and is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended.

IMPORTANT INFORMATION AND WHERE TO FIND IT

In connection with the transaction, AGH has filed a registration statement on Form S-4 with the SEC, which includes an information statement and prospectus of AGH, and has mailed a definitive information statement and prospectus to its stockholders. Investors and security holders are urged to read the registration statement (and any other documents filed with the SEC in connection with the transaction or incorporated by reference into the registration statement) because such documents contain important information regarding the proposed transaction and related matters. Investors and security holders may obtain free copies of these documents and other documents filed with the SEC by AGH through the website maintained by the SEC at http://www.sec.gov or at AGH’s website at https://www.aureusgreenway.com/secfilings.

AGH has not independently verified and makes no representation or warranty, express or implied, as to the accuracy, completeness, or reliability of the information in this release relating to the business, operations, financial condition, technology, products, certifications, contracts, or prospects of Powerus or its subsidiaries. Such information has been provided by Powerus, and AGH disclaims any obligation to update or correct such information.

CONTACTS

AGH Investor Relations
Jason Assad
678-570-6791

Powerus Press Contact
Escalate PR
pr@power.us

Year-to-date bookings of $16.2 million include a combination of fit-for-purpose multi-modal datasets, datasets-plus-license arrangements, and multi-year platform access licenses; a significant portion of these bookings are expected to be delivered during the remainder of the year

MINNEAPOLIS, Sept. 18, 2026 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced year-to-date bookings of approximately $16.2 million, a 16X increase versus the same period in 2025. A significant portion of these bookings are expected to be delivered during the remainder of the year.

Approximately 50% of the contracts booked during 2026 are with new customers to OneMedNet, while the existing customer base continues to expand their business with the Company through high rates of reorder and follow-on engagement.

Platform improvements have increased OneMedNet’s order-fulfillment speed by approximately 50X, accelerating how quickly the Company can assemble, qualify, and deliver fit-for-purpose multi-modal datasets. This increase in speed allows the Company to take on large orders while providing quick delivery to meet our customers’ project schedules.

Life sciences, medical device, and AI organizations continue to use OneMedNet’s iRWD™ Platform for regulatory submissions, foundation-model development, cohort discovery, feasibility studies, and high-value research, which is reflected in our bookings backlog. This builds on our network of more than 2,300 healthcare partner sites and more than 90 million patient journeys and 270 million studies.

Key Highlights

  • Contracted demand: Approximately $16.2 million in year-to-date bookings, a 16X increase over the same period in 2025.
  • Growth from new and existing customers: Approximately 50% of contracts booked during 2026 are with new customers to OneMedNet, complemented by reorder and expansion activity from existing customers.
  • Faster fulfillment: Order fulfillment is approximately 50X faster, which allows the Company to take on larger orders and deliver faster.

“Our commercial engine is delivering,” said Aaron Green, CEO & President. “Bookings are up more than 16X year over year, and we are executing to our contracted delivery schedules. Expanding demand combined with disciplined execution is what builds durable value. The market is shifting decisively towards direct-from-source, regulatory grade Real-World Data, and OneMedNet through our provider network and advanced technology is positioned to deliver it at the speed, scale, and quality that modern healthcare innovation demands.”

About OneMedNet Corporation

OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the potential of more than 2,300 healthcare sites through its iRWD™ platform. This is not just data — it is the foundation of innovation, from de-identified medical imaging to electronic health records, fueling work for drugmakers, medical device companies, and AI developers. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that support patient care and the next wave of healthcare innovation.

Learn more at www.onemednet.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release are forward-looking statements. These statements include, but are not limited to, statements regarding demand for our products and services, the composition and durability of our customer base, the speed of order fulfillment, the acceptance of our delivered data sets allowing for the conversion of bookings to revenue, our ability to achieve our operational strategies, our expected growth in the business, and statements generally about our products, plans and strategies.

Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include, but are not limited to: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; the timing of customer acceptance and data delivery; and the other risks described in our most recent Annual Report on Form 10-K and our subsequent filings with the Securities and Exchange Commission. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

OneMedNet Contacts:
Michael Wong, VP Marketing
Email: michael.wong@onemednet.com

WEST DES MOINES, Iowa and NEW YORK, Sept. 18, 2026 (GLOBE NEWSWIRE) — Athene Holding Ltd (“Athene”) and Imran Siddiqui today jointly announce that they have resolved the legal proceedings commenced by Athene against Mr. Siddiqui and Caldera Holdings Limited in May 2018 in the Supreme Court of Bermuda. As part of this resolution, Mr. Siddiqui agreed to make the following statement:

“Athene has compromised its claim with Mr Siddiqui and Caldera Holdings Limited. The terms of settlement are confidential.

However, Mr Siddiqui has agreed as part of that agreement to acknowledge that in 2016 and 2017, he sent and received documents which contained information which was confidential to Athene in connection with the establishment of Caldera, a competitive company he was trying to set up.

Mr Siddiqui acknowledges that, in behaving in this way, he breached fiduciary duties which he owed to Athene. Mr Siddiqui did not think that at the time, but on reflection he now acknowledges that he should have known that sending and receiving the documents that he did was a breach of his obligations.”

The parties will not comment further on this matter.

CONTACT: Contact:
externalrelations@athene.com

WEST DES MOINES, Iowa, Sept. 18, 2026 (GLOBE NEWSWIRE) — West Bancorporation, Inc. (Nasdaq: WTBA) (the “Company”), parent company of West Bank, will report its results for the third quarter of 2026 on Thursday, October 29, 2026 before the markets open.

The Company will discuss its results in a conference call scheduled for 2:00 p.m. Central Time on Thursday, October 29, 2026. The telephone number for the conference call is 833-461-5787. The meeting ID for the conference call is 761930850. A recording of the call will be available until November 12, 2026, by dialing 833-309-1852. The meeting ID for the replay call is 761930850.

West Bancorporation, Inc. is headquartered in West Des Moines, Iowa. Serving its customers since 1893, West Bank, a wholly-owned subsidiary of West Bancorporation, Inc., is a community bank that focuses on lending, deposit services and trust services for consumers and small- to medium-sized businesses. The Bank has six offices in the greater Des Moines, Iowa area, one office in Coralville, Iowa, and four offices in Minnesota, in the cities of Rochester, Mankato, Owatonna and St. Cloud.

For more information contact:
Jane Funk, Executive Vice President, Treasurer and Chief Financial Officer (515) 222-5766

NEW YORK, Sept. 18, 2026 (GLOBE NEWSWIRE) — AMC Robotics Corporation (Nasdaq: AMCI) (“AMC Robotics” or the “Company”), an AI-driven robotics solutions provider, today announced it has entered into a $50 million standby equity purchase agreement (the “Agreement”). In connection with the Agreement, an institutional investor (the “Investor”) loaned the Company $3.88 million in exchange for convertible promissory notes (the “Notes”), to be funded in two tranches, subject to certain conditions. The net proceeds received under the terms of the Agreement are expected to fund the buildout and production line commissioning of the Company’s robotic manufacturing facility, targeted for completion by November 2026.

Pursuant to the Agreement, the Company has the right, but not the obligation, to issue and sell up to $50 million in aggregate gross purchase price of newly issued shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), subject to certain conditions, including that a registration statement covering the resale of the Common Stock be filed and declared effective by the Securities and Exchange Commission (“SEC”). The Company cannot draw on the funds available under the Agreement, and the Common Stock may not be sold nor may offers to buy be accepted, prior to the time that the registration statement covering the resale of the Common Stock is declared effective by the SEC.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

The Notes will mature one year after the issuance date and may be repaid by issuing shares to the Investor at the lower of (i) $4.017 per share (the “Fixed Price”), or (ii) 92% of the lowest daily VWAP during the 5 consecutive trading days immediately preceding the payment date or other date of determination. The Company, in its sole discretion, has the right to prepay the Investor in cash, in whole or in part, any outstanding principal amount under the Notes prior to the Maturity Date, an amount equal to the amount being prepaid plus a prepayment premium equal to 6% of the outstanding principal amount being prepaid. While any amount remains outstanding under the Notes, Company-initiated advances are generally limited except if certain conditions are met under the Agreement, and the Investor may, in its sole discretion, deliver a notice requiring the Company to issue and sell Common Stock to the Investor in an amount up to, but not exceeding, the outstanding balance of the Notes. The Notes contain standard and customary terms and conditions for transactions of similar nature.

Sean Da, AMC Robotics’ Chief Executive Officer, stated, “The standby equity purchase agreement gives AMCI additional means and flexibility to raise capital on company-friendly terms, and represents an attractive cost of capital. Additionally, we expect that the advance through the issuance of the Notes will allow us to start production at our robotic manufacturing facility ahead of our original schedule. We now believe we are well-situated to raise capital in a cost-effective and accretive manner to penetrate the warehouse and industrial robotics market.”

For additional information about the transactions described in this press release, see the Company’s Current Report on Form 8-K, which will be filed promptly following the issuance of this press release and which can be obtained, without charge, at the Securities and Exchange Commission’s internet site (http://www.sec.gov).

About AMC Robotics Corporation

AMC Robotics (Nasdaq: AMCI) is an AI-driven robotics company focused on developing intelligent, scalable hardware and software solutions. The Company’s quadruped robotic platform, Kyro™, enables industries to automate inspection, security, and operational tasks through autonomous mobility and AI-powered perception and its warehouse logistics sorting robot, NovaArm™ is designed to enhance operational efficiency, improve sorting accuracy, and reduce labor costs for warehouses and distribution centers, addressing the accelerating demand for automation across the U.S. logistics sector.

For more information, please visit www.amcx.ai.

Investors and Media Contact
Susan Xu
Alliance Advisors IR
E: AMCRoboticsIR@allianceadvisors.com 

Cautionary Note Regarding Forward Looking Statements
This press release may contain statements that constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning the Company’s possible or assumed future results of operations, business strategies, debt levels, competitive position, industry environment, potential growth opportunities, and the effects of regulation. These forward-looking statements are based on the Company’s management’s current expectations, projections, and beliefs, as well as a number of assumptions concerning future events. When used in this communication, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose,” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.

These forward-looking statements are not guarantees of future performance, conditions, or results, and involve a number of known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside of the Company’s control, that could cause actual results to differ materially from the results discussed in the forward-looking statements, including statements regarding the management’s expectations, hopes, beliefs, intentions, plans, prospects or strategies regarding the anticipated use of proceeds received under the terms of the Agreement . These risks, uncertainties, assumptions, and other important factors include, but are not limited to: (a) challenges in opening operations in new jurisdictions, including but not limited to compliance with local ordinances, obtaining any necessary permits and regulatory oversight; (b) the ability to recognize the anticipated benefits of the new operations; (c) the outcome of any legal proceedings that may be instituted against the Company; (d) the ability to continue to meet the applicable stock exchange listing standards; (e) the ability to recognize the anticipated benefits of the transaction with AlphaVest, which may be affected by, among other things, competition, the ability of the Company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (f) changes in applicable laws or regulations, including legal or regulatory developments (including, without limitation, accounting considerations); (g) the possibility that AMC Robotics may be adversely affected by other economic, business, and/or competitive factors; (h) AMC Robotics’ estimates of expenses and profitability; (i) AMC Robotics’ ability to satisfy the conditions precedent to the use of the funds available under the terms of the Agreement on a timely basis, if at all; (j) buildout and production line commissioning of the Company’s robotic manufacturing facility and the corresponding target completion date; and (k) other risks and uncertainties indicated under “Risk Factors” contained in AMC Robotics’ Annual Report on Form 10-K for the year ended December 31, 2025 and other documents filed or to be filed with the SEC by AMC Robotics. Copies are available on the SEC’s website, www.sec.gov. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made.

The Company assumes no obligation and, except as required by law, does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. The Company gives no assurance that it will achieve its expectations.

Year-to-date SteraMist iHP Service and Support sales of approximately $1.7 million reflects a roughly 31% increase over full-year 2025, underscoring the growing recurring-revenue contribution of TOMI’s contracted service base

FREDERICK, Md., Sept. 18, 2026 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today reported continued acceleration in its SteraMist iHP Service and Support business. Year-to-date SteraMist iHP Service and Support sales of approximately $1.7 million has surpassed both 2024 and 2025 iHP Service and Support revenue, each of which totaled approximately $1.3 million.

This growth in SteraMist iHP Service and Support revenue underscores the increasing recurring-revenue mix of contracted iHP decontamination service and ongoing on-site support engagements. During the year, TOMI has completed multiple contracted SteraMist iHP decontamination service engagements, including deployments with Integra Pharma and Catalent, each four times year-to-date, in addition to contracted engagements with Cleveland Clinic and LFB USA. TOMI also maintains an ongoing SteraMist iHP service relationship with a Canadian university, serviced four times year-to-date. TOMI continues to deliver on-site support services on a recurring basis, averaging approximately four visits per month, at facilities including the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, along with other government and commercial accounts.

“We are seeing sustained demand for deployable SteraMist iHP service and support,” said Reed A. Scott, iHP Service Director and Quality Service Engineer at TOMI Environmental Solutions. “SteraMist allows us to complete a service job quickly, so facilities can return to operations with minimal downtime. Customers consistently point to our turnaround time, reporting, and professionalism, and as we continue to grow and see more opportunities worldwide, we look forward to delivering recurring contracted service that keeps their environments and personnel safely protected.”

The growth in SteraMist iHP Service and Support revenue adds to TOMI’s broader revenue diversification strategy, complementing system sales and reinforcing recurring engagement across TOMI’s installed base. TOMI remains focused on expanding its contracted service accounts and on-site support for the remainder of fiscal 2026.

About TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®

TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global decontamination and infection prevention company providing environmental disinfection and bio-decontamination solutions through manufacturing, sales, and licensing of its Binary Ionization Technology® (BIT®) platform. Developed under a defense grant with DARPA, BIT® utilizes low-percentage hydrogen peroxide to produce ionized hydrogen peroxide (iHP®) fog. SteraMist® products serve hospitals, laboratories, government and military installations, cruise ships, office buildings, schools, restaurants, food processing facilities, and residences, delivering protection against a broad range of bacteria, viruses, mold, mycotoxins, and biological and chemical warfare agents. For additional information, please visit https://www.steramist.com or contact us at info@tomimist.com.

Forward-Looking Statements

This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s products and services to serve the life science sector. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to acquire new customers and expands sales; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.

INVESTOR RELATIONS CONTACT:  

John Nesbett/Zach Nevas

IMS Investor Relations  

tomi@imsinvestorrelations.com  

8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)   Full name of discloser: Rathbones Group Plc
(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
 
(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
        Use a separate form for each offeror/offeree
NextEnergy Solar Fund Ltd
(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  
(e)   Date position held/dealing undertaken:
        For an opening position disclosure, state the latest practicable date prior to the disclosure
17/09/2026
(f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
        If it is a cash offer or possible cash offer, state “N/A”
No

2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

Ordinary NPV
  Interests Short positions
  Number % Number %
(1)   Relevant securities owned and/or controlled: 5,834,109 1.01%    
(2)   Cash-settled derivatives:

       
(3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        

        TOTAL:

5,834,109 1.01%    

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)      Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security Purchase/sale

Number of securities Price per unit
Ordinary NPV Sale 13,450 49.2605p

(b)        Cash-settled derivative transactions

Class of relevant security Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities Price per unit
         

(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
e.g. American, European etc.
Expiry date Option money paid/ received per unit
               

(ii)        Exercise

Class of relevant security Product description
e.g. call option
Exercising/ exercised against Number of securities Exercise price per unit
         

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing
e.g. subscription, conversion
Details Price per unit (if applicable)
Ordinary NPV      

4.        OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i)   the voting rights of any relevant securities under any option; or
(ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”
None

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached? No

Date of disclosure: 18/09/2026
Contact name: Hannah Collins – Compliance Department
Telephone number: 0151 243 7103

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at.

MAYFIELD VILLAGE, OHIO, Sept. 18, 2026 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended August 31, 2026:

  August
(millions, except per share amounts and ratios; unaudited) 2026   2025   Change
Net premiums written $ 7,605   $ 7,199   6   %
Net premiums earned $ 7,354   $ 7,036   5   %
Net income $ 951   $ 1,220   (22 ) %
Per share available to common shareholders $ 1.63   $ 2.07   (21 ) %
Total pretax net realized gains (losses) on securities $ 108   $ 78   38   %
Combined ratio   89.3     83.1   6.2   pts.
Average diluted equivalent common shares   582.1     588.1   (1 ) %

  August 31,
(thousands; unaudited) 2026   2025   % Change
Policies in Force          
Personal Lines          
Agency – auto 11,343   10,575   7
Direct – auto 16,879   15,524   9
Special lines 7,378   6,955   6
Property 3,647   3,639   0
Total Personal Lines 39,247   36,693   7
Commercial Lines 1,245   1,197   4
Total 40,492   37,890   7
           
           

See Progressive’s complete monthly earnings release for additional information.

About Progressive

Progressive Insurance® makes it easy to understand, buy and use car insurance, home insurance, and other protection needs. Progressive offers choices so consumers can reach us however it’s most convenient for them — online at progressive.com, by phone at 1-800-PROGRESSIVE, via the Progressive mobile app, or in-person with a local agent.

Progressive provides insurance for personal and commercial autos and trucks, motorcycles, boats, recreational vehicles, and homes; it is a leading seller of personal auto, commercial auto, motorcycle, and boat insurance, and one of the top 15 homeowners insurance carriers in the United States. 

Founded in 1937, Progressive continues its long history of offering shopping tools and services that save customers time and money, like Name Your Price®, Snapshot®, and HomeQuote Explorer®.

The Common Shares of The Progressive Corporation, the Mayfield Village, Ohio-based holding company, trade publicly at NYSE: PGR.

Company Contact:
Julianna Paterra, CFA
(719) 432-2509
investor_relations@progressive.com

The Progressive Corporation 
300 North Commons Blvd.
Mayfield Village, Ohio 44143
http://www.progressive.com

Download PDF: Progressive August 2026 Complete Earnings Release

8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)   Full name of discloser: Rathbones Group Plc
(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
 
(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
        Use a separate form for each offeror/offeree
Eleco Plc
(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  
(e)   Date position held/dealing undertaken:
        For an opening position disclosure, state the latest practicable date prior to the disclosure
17/09/2026
(f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
        If it is a cash offer or possible cash offer, state “N/A”
No

2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

1p Ordinary Shares
  Interests Short positions
  Number % Number %
(1)   Relevant securities owned and/or controlled: 1,158,470 1.37%    
(2)   Cash-settled derivatives:

       
(3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        

        TOTAL:

1,158,470 1.37%    

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)      Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security Purchase/sale

Number of securities Price per unit
1p Ordinary Shares Sale 4,560 229.31p

(b)        Cash-settled derivative transactions

Class of relevant security Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities Price per unit
         

(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
e.g. American, European etc.
Expiry date Option money paid/ received per unit
               

(ii)        Exercise

Class of relevant security Product description
e.g. call option
Exercising/ exercised against Number of securities Exercise price per unit
         

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing
e.g. subscription, conversion
Details Price per unit (if applicable)
1p Ordinary Shares      

4.        OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i)   the voting rights of any relevant securities under any option; or
(ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”
None

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached? No

Date of disclosure: 18/09/2026
Contact name: Hannah Collins – Compliance Department
Telephone number: 0151 243 7103

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.